Glaxo SmithKline Pharmaceuticals announced a marginal rise in standalone net profit for the quarter ended March 2016. During the quarter, the profit of the company rose 3.04% to Rs 1,059.80 million from Rs 1,028.50 million in the same quarter last year.
Revenues for the quarter rose 12.96% to Rs 6,929.70 million, compared with Rs 6,135 million for the prior year period.
Earnings per share for the quarter stood at Rs 12.50, registering 3.31% growth over previous year period.
| Quarterly Results - Standalone (Rs in mn) |
| As at | Mar - 16 | Mar - 15 | %Change |
| Revenues | 6,929.70 | 6,134.70 | 12.96 |
| Net Profit | 1,059.80 | 1,028.50 | 3.04 |
| Diluted EPS | 12.50 | 12.10 | 3.31 |
Shares of the company gained Rs 32.15, or 0.95%, to settle at Rs 3,425.30. The total volume of shares traded was 1,917 at the BSE (Wednesday).
